RxDoctor Payments Data

Richard Coursey, MD

Vascular & Interventional Radiology · Greeley, CONPI 1821294695

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 87.6% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $12,362, 6.7 times the $1,846 reported in 2019.

$31,097in general payments, 2019–2025

Across 206 payments — averaging $150.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$27K
  • Bard Peripheral Vascular, Inc.$2K
  • Argon Medical Devices, Inc.$278
  • SPR Therapeutics, Inc$261
  • Boston Scientific$220
  • Angiodynamics, Inc.$207
  • plus $553 from 8 others

What the payments were for

  • Consulting fees$6,55021%
  • Speaking & faculty fees$12,00039%
  • Travel & lodging$7,71625%
  • Food & beverage$4,83116%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,097 in reported general payments places this provider in the 80th percentile of 105 vascular & interventional radiology providers in Colorado.

See all vascular & interventional radiology providers in Colorado

Medicare billing

Part B allowed, 2024
$79,425
Medicare patients
226
Services billed
680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl21$414
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$335
Cilostazol13$310
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$224
Amlodipine Besylate13$174
Gabapentin18$149
Tramadol Hcl40$123

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Greeley

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →